Sarepta Therapeutics, Inc. · NASDAQ:SRPT
Rodino-Klapac Louise had 21,423 Sarepta Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 4, 2026 · Filed Sep 8, 2026
On Sep 4, 2026, Rodino-Klapac Louise (President, R&D and Tech Ops) had 21,423 Sarepta Therapeutics, Inc. shares withheld for tax at US$22.22 for US$476K, leaving 203,900 shares. Filed Sep 8, 2026 (Form 4).
- Withheld for tax
- 21,423 shares
- Price
- US$22.22
- Value
- US$476K
- Holding after
- 203,900 shares
- Trading plan
- No
- Role
- President, R&D and Tech Ops
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Shares withheld for tax | 21,423 | US$22.22 | 203,900 | Direct |
Source
Related
- Sarepta Therapeutics, Inc.
- Rodino-Klapac Louise
- Sarepta Therapeutics, Inc. shareholders
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026